Global Rx-to-OTC Switches Industry has the potential to be valued at US$ 66.5 Billion by 2033, according to FMI

The global Rx-to-OTC switches industry is set to experience substantial expansion, with an estimated valuation of US$ 38.7 billion in 2023 and a projected surge to US$ 66.5 billion by 2033. This robust growth is anticipated to be driven by a compound annual growth rate (CAGR) of 5.6% during the forecast period. The Rx-to-OTC switches …

Global Rx-to-OTC Switches Industry is anticipated by FMI to potentially attain a valuation of US$ 66.5 Billion by 2033

TheĀ global Rx-to-OTC switches industry sizeĀ is estimated to register a valuation of US$ 38.7 billion in 2023 and is predicted to reach US$ 66.5 billion by 2033. The market is estimated to capture a CAGR of 5.6% during the forecast period. The Rx-to-OTC switches market, which refers to the transition of prescription drugs into over-the-counter (OTC) …